Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,262.56 89.32 0.55%
S&P 500 1,842.98 12.37 0.68%
NASDAQ 4,034.16 11.47 0.29%
Ticker Volume Price Price Delta
STOXX 50 3,123.84 32.32 1.05%
FTSE 100 6,569.41 27.80 0.42%
DAX 9,259.60 85.89 0.94%
Ticker Volume Price Price Delta
NIKKEI 14,417.68 420.87 3.01%
TOPIX 1,166.55 30.46 2.68%
HANG SENG 22,696.01 24.75 0.11%

RECKITT BENCKISER GROUP PLC: Completion of Collaboration Agreement


RECKITT BENCKISER GROUP PLC: Completion of Collaboration Agreement 20 May 2013

RECKITT BENCKISER ANNOUNCES COMPLETION OF LATAM OTC COLLABORATION AGREEMENT

WITH BRISTOL-MYERS SQUIBB

Slough, England - 20 May, 2013 - Reckitt Benckiser Group PLC ("RB") (LSE: RBL) announces that the three year collaboration agreement signed with Bristol-Myers Squibb Company (NYSE: BMY) on 10 February 2013 has been completed and that regulatory approvals, including anti-trust approvals in the relevant jurisdictions, have now been obtained.

The terms of the agreement include the transfer of personnel, supply contracts and an option to acquire legal title to the related intellectual property at the end of the collaboration period, based on business performance. Reckitt Benckiser will account for the transaction as a business combination.

ENDS

Investor & Analyst Contacts:

Reckitt Benckiser (RB)

Richard Joyce

Director, Investor Relations

+44 1753 217800

Media Contacts:

Reckitt Benckiser (RB)

Andraea Dawson-Shepherd

SVP, Global Corporate Communication & Affairs

+44 1753 446447

Brunswick (Financial PR)

David Litterick / Max McGahan

+44 (0)20 7404 5959

END

-0- May/20/2013 06:00 GMT

Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement